European Cannabis Insights Summit 2026: Patients & Politics Post-Reclassification
Since April 2024, Berlin has cemented its place as the spiritual centre of the European cannabis industry.
Since April 2024, Berlin has cemented its place as the spiritual centre of the European cannabis industry.
Mere hours after the results of the US election became clear, sending North American cannabis stocks into freefall, Germany’s ruling traffic light coalition all but collapsed, throwing the future of Europe’s largest and most promising cannabis market into uncertain territory.
Last week, Hanover and Frankfurt published ‘letters of intent’ to launch controlled cannabis sales to thousands of participants through new model projects, designed to gather data and inform future drug policy in Germany.
Germany’s flourishing medical cannabis market is now forecast to top €420m this year, according to Prohibition Partners’ upcoming German Cannabis Report.
Germany’s long-anticipated ‘Pillar 2’ is in danger of being abandoned by the government amid ongoing political roadblocks both domestically and from the EU.
Germany’s highly anticipated ‘Pillar 2’, which would seek to implement a Switzerland-style adult-use cannabis pilot project model, is now being worked on by the German government.